Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

ClinicalTrials.gov ID: NCT04620239

Public ClinicalTrials.gov record NCT04620239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer

Study identification

NCT ID
NCT04620239
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Steba Biotech S.A.
Other
Enrollment
100 participants

Conditions and interventions

Interventions

  • padeliporfin VTP Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2021
Primary completion
Mar 29, 2026
Completion
Jan 24, 2029
Last update posted
Feb 3, 2026

2021 – 2029

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
University of California - Irvine Medical Center Irvine California 92868 Recruiting
Keck School of Medicine at USC Medical Center Los Angeles California 90033 Recruiting
Emory University Hospital Atlanta Georgia 30322 Recruiting
The Johns Hopkins Hospital, The Sidney Kimmel Cancer Center Baltimore Maryland 21287 Recruiting
Albany Medical College Albany New York 12208 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
The Ohio State University (OSU) Columbus Ohio 43210 Recruiting
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center Hershey Pennsylvania 17033 Recruiting
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 Recruiting
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 Recruiting
University of Texas Southwestern Dallas Texas 75390 Recruiting
University of Washington Seattle Washington 98195 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04620239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04620239 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →